Codexis, Inc. Form 8-K Summary
Business Context and Reporting Period
Company: Codexis, Inc. (CDXS)
Filing Date: September 7, 2023
Event Date: September 1, 2023
Reporting Period: Current Report (8-K) regarding a specific material event.
The Company entered into an Assignment and Assumption of Lease with Vaxcyte, Inc. to transfer its leasehold interest in approximately 36,593 square feet of office space located at 825 Industrial Road, San Carlos, California.
Key Financial Metrics
This filing does not report standard financial performance metrics such as revenue, profit, cash flow, or margins. The only specific financial figures disclosed relate to the lease transaction:
- Security Deposit: Approximately $0.4 million (to be returned to the Company via letter of credit).
- Prepayments: The Company will prepay Base Rent for a three-month period commencing on the Assignment date and certain amounts for tenant improvements.
Material Changes
The primary material change is the termination of the Company's lease obligations for the San Carlos premises and the assumption of those obligations by Vaxcyte. Key terms include:
- Release of Obligations: The Landlord agreed to release Codexis from all lease obligations accruing from and after the Assignment date.
- Return of Deposit: The Landlord agreed to return the Company's security deposit following the Assignment.
- Improvements: Neither party is required to remove existing alterations or improvements to the Premises.
- Termination Clause: Vaxcyte may terminate the Assignment Agreement if the Assignment does not occur by January 1, 2024, subject to force majeure extensions.
Outlook, Management Commentary, and Risks
Management Commentary: The transaction aligns with the Company's strategy to focus resources on programs with the strongest commercial opportunity and highest probability of near-term success. It supports previously announced initiatives to streamline operations and consolidate operations to the Company's headquarters.
Risks and Contingencies: The Assignment is contingent on Vaxcyte occupying the Premises or the Company vacating and decommissioning the space. If the Assignment is not completed by January 1, 2024, Vaxcyte retains the right to terminate the agreement.
Investor Verification Checklist
- Verify the exact date the Assignment becomes effective to confirm when lease obligations cease.
- Confirm the total amount of prepayments made for the three-month rent period and tenant improvements.
- Review the upcoming Form 10-Q for the quarter ended September 30, 2023, for the full text of the Assignment Agreement.
- Monitor whether the Company successfully consolidates operations to its headquarters as stated in the strategy.